The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since

This is a generated summary. It shows the 9 most-liked posts from a topic of 133, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
CH
c.haddadTL231 Aug 2024#5
appeals_desk, post #2: The opening post describes the usual case. This is about the unusual one. What I would want before treating Semaglutide half-life as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually missing. Go to post

Understood, and I withdraw the assumption I opened with.

31 likes in reply to #2 23mo
ZO
z.okonkwoTL25 Nov 2024#38

On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species. Mass narrows the field; it does not close it, and no certificate should be read as though it did.

33 likes 21mo
JF
j.falkTL215 Dec 2024#63
se.okafor, post #48: The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the acylation is another. Different sources emphasise different details. A single observation, in a thread that deserves better than single observations. Go to post

Semaglutide half-life is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before adding to this one.

33 likes in reply to #48 19mo
D
DSakamotoTL3Regular3 Jan 2025#76

Confirming post #75 from a second method, which matters more than confirming it from a second person.

An honest declaration on Semaglutide half-life: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.

32 likes 19mo
MI
m.ibarraTL211 Jan 2025#82

This is the answer, and the reason it is the answer is the more useful part.

32 likes 19mo
SB
s.bergstromTL221 Jan 2025#89

This follows post #88 rather than contradicting it.

Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a fatty side chain, which creates a very long half-life at the cost of sequestering the free form. That is a trade-off and it is the trade-off that allows weekly dosing.

30 likes 18mo
KP
k.pereiraTL228 Jan 2025#94
d.vestergaard, post #69: On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower escalation was not studied. That means the evidence supports not going faster and says nothing at all about going slower. That is what I would do. It may not be what is correct. Go to post

On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval is not arbitrary — it is what stops two doses stacking inside one absorption window.

This is the version I would want a new member to read first.

30 likes in reply to #69 18mo
AK
ar.kravchenkoTL226 Feb 2025#116
m.wanjala, post #109: Before the thread moves on from Semaglutide half-life — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four and from an n of four hundred. Go to post

Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason a plain sequence comparison against native GLP-1 is misleading about how the molecule behaves.

30 likes in reply to #109 17mo
FP
forest_plotTL3Evidence synthesis19 Mar 2025#132
r.ekstrom, post #86: The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is the pharmacological argument for the four-week step interval. Nothing above should be read as advice about what anyone else should do. Go to post

The failure mode on Semaglutide half-life is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

33 likes in reply to #86 16mo

Read the full topic (133 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile
Posting this under the heading it deserves: Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Everything below is what sits behind that. Semaglutide and gastric emptying,…
DEIBHMMMCN+115 122 2.6k 1d
About the Semaglutide category
GLP-1 receptor agonist. Dosing, published trial data, tolerability, and formulation questions. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with…
TVJMRJGOMH 4 4.2k 11mo
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Writing it up because I had to work it out twice and would rather nobody else did. Putting the numbers in the first…
VSFVSC 2 39k 6mo
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide
Posting this under the heading it deserves: Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Everything below is what sits behind that. I have spent a fortnight trying…
UCZACNSKGF+72 77 7.2k 19mo
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit?
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? — that is the question, and I have not found it answered plainly anywhere I have looked. Putting the numbers in the first…
AWBWCEPLEK+5 9 30k 8d

Related topics — sharing the tags STEP programme, type 2 diabetes, randomised trial

TopicParticipantsRepliesViewsActivity
Comparators chosen for regulatory reasons rather than clinical ones
On the subject in the title: Comparators chosen for regulatory reasons rather than clinical ones Working notes rather than a conclusion. An honest uncertainty about comparators chosen for regulatory reasons…
PESZTD 2 27k 14mo
Measurement error in home scales, with a worked standard deviation
Measurement error in home scales, with a worked standard deviation Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of measurement error…
TKSTVMDEB+26 31 4.3k 4mo
Adjudicated events and why the definition matters — the long version
Adjudicated events and why the definition matters — the long version Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Adjudicated events, deliberately…
JSEFIBSSRE+125 146 13k 15mo
Journal club: FLOW and the renal composite, component by component
On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Reading FLOW ( N Engl J Med , 2024) for the population rather than the…
ACNNZLHEAW+84 91 18k 2y
An ABAB design with a data table and honest limitations — a second dataset
On the subject in the title: An ABAB design with a data table and honest limitations — a second dataset Working notes rather than a conclusion. Posting a small dataset on ABAB design. It is mine, it is…
VELIGRAC+106 118 25k 4mo